|Articles|July 25, 2022
Osmolality monitoring for UF/DF and CEX capture of mAbs from mammalian cell cultures
Author(s)Advanced Instruments
The goal of this paper is to introduce and support the use of osmolality in the Downstream Ultrafiltration/Diafiltration (UF/DF) process steps in the mAb workflow.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
AdvanCell Targets GI Cancer With Peptide-Driven Lead-212 Radiotherapy
3
Genentech Expands RNAi Pipeline Through Global Licensing Deal
4
Pfizer Phase IIb Data Support Monthly GLP-1 Dosing for Obesity
5